Lithium carbonate: Maintenance studies and consequences of withdrawal

Journal of Clinical Psychiatry

Volumn 59, Issue SUPPL. 6, 1998, Pages 48-56

  Dunner, David L ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLOZAPINE; IMIPRAMINE; LITHIUM CARBONATE; THIORIDAZINE; VALPROIC ACID;

BIPOLAR DEPRESSION; CLINICAL TRIAL; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG WITHDRAWAL; ELDERLY CARE; FAMILY HISTORY; HUMAN; MAINTENANCE THERAPY; MAJOR DEPRESSION; MANIC DEPRESSIVE PSYCHOSIS; MORTALITY; PATIENT COMPLIANCE; PATIENT SELECTION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW;

BIPOLAR DISORDER; HUMANS; LITHIUM CARBONATE; MOOD DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0031864583     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Psychiatric diagnosis in New York and London: a comparative study of mental hospital admissions. In: Cooper JE, Kendell RE, Gurland BJ, et al, eds. Maudsley Monograph No. 20. London, England: Oxford University Press, 1972
2. Baastrup PC, Schou M. Lithium as a prophylactic agent: its effect against recurrent depressions and manic-depressive psychosis. Arch Gen Psychiatry 1967;16:162-172
3. Blackwell B, Shepherd M. Prophylactic lithium: another therapeutic myth? Lancet 1968;1:968-971
4. Fieve RR. The lithium clinic: a new model for delivery of psychiatric services. Am J Psychiatry 1975;132:1018-1022
5. Baastrup PC, Poulsen JC, Shou M, et al. Prophylactic lithium: double-blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet 1970;2:326-330
6. Melia PL. Prophylactic lithium: a double-blind trial in recurrent affective disorders. Br J Psychiatry 1970;116:621-624
7. Coppen A, Noguera R, Bailey J, et al. Prophylactic lithium in affective disorders: controlled trial. Lancet 1971;2:275-279
8. Coppen A, Peet M, Bailey J, et al. Double-blind and open prospective studies of lithium prophylaxis in affective disorders. Psychiatr Neurol Neurochir 1973;76:500-510
9. Cundall RL, Brooks PW, Murray LG. A controlled evaluation of lithium prophylaxis in affective disorders. Psychol Med 1972;2:308-311
10. Stallone F, Shelley E, Mendlewicz J, et al. The use of lithium in affective disorders. III: a double blind study of prophylaxis in bipolar illness. Am J Psychiatry 1973;130:1006-1010
11. Prien RF, Caffey EM Jr, Klett CJ. Prophylactic efficacy of lithium carbonate in manic-depressive illness. Arch Gen Psychiatry 1973;28:337-341
12. Prien RF, Klett CJ, Caffey EM Jr. Lithium carbonate and imipramine in prevention of affective episodes: a comparison in recurrent affective illness. Arch Gen Psychiatry 1973;29:420-425
13. Fieve RR, Kumbaraci T, Dunner DL. Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients. Am J Psychiatry 1976;133: 925-930
14. Dunner DL, Stallone F, Fieve RR. Lithium carbonate and affective disorders, V: a double-blind study of prophylaxis of depression in bipolar illness. Arch Gen Psychiatry 1976;33:117-120
15. Quitkin F, Rifkin A, Kane J, et al. Prophylactic effect of lithium and imipramine in unipolar and bipolar II patients: a preliminary report. Am J Psychiatry 1978;135:570-572
16. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York, NY: Oxford University Press; 1980
17. Dunner DL, Stallone F, Fieve RR. Prophylaxis with lithium carbonate: an update. Arch Gen Psychiatry 1982;39:1344-1345
18. Dunner DL, Fieve RR. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 1974;30:229-233
19. Winokur G, Clayton PJ, Reich T. Manic Depressive Illness. St. Louis, Mo: C. V. Mosby Company; 1969
20. Dunner DL, Murphy D, Stallone F, et al. Episode frequency prior to lithium treatment in bipolar manic-depressive patients. Compr Psychiatry 1980;20: 511-515
21. Fleiss JL, Prien RF, Dunner DL, et al. Actuarial studies of the course of manic-depressive illness. Compr Psychiatry 1978;19:355-362
22. Tohen M, Waternaux CM, Tsuang MT, et al. Four-year follow-up of twenty-four first-episode manic patients. J Affect Disord 1990;19:79-86
23. Gelenberg AJ, Kane JM, Keller MB, et al. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 1989;321:1489-1493
24. Moreno FA, Gelenberg AJ, Hopkins HA, et al. Maintenance treatment of bipolar disorder. In: Dunner DL, ed. Current Psychiatric Therapy, II. Philadelphia, Pa: WB Saunders Company; 1997;271-282
25. Wehr TA, Goodwin FK. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry 1979;36:555-559
26. Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of depressive illness? Am J Psychiatry 1987;114:1403-1411
27. Wehr TA, Sack DA, Rosenthal NE, et al. Rapid cycling affective disorder: contributing factors and treatment response in 51 patients. Am J Psychiatry 1988;145:179-184
28. Zornberg GL, Pope HG Jr. Treatment of depression in bipolar disorder: new directions for research. J Clin Psychopharmacol 1993;13:397-408
29. Scott J. Psychotherapy for bipolar disorder. Br J Psychiatry 1995;167: 581-588
30. American Psychiatric Association: Practice Guideline for the Treatment of Patients With Bipolar Disorder. Am J Psychiatry 1994;151(12, suppl)
31. Bocchetta A, Bernardi F, Burrai C, et al. The course of thyroid abnormalities during lithium treatment: a two-year follow-up study. Acta Psychiatr Scand 1992;86:38-41
32. Kallner G, Petterson U. Renal, thyroid and parathyroid function during lithium treatment: laboratory tests in 207 people treated for 1-30 years. Acta Psychiatr Scand 1992;86:38-41
33. 33: Bauer MS, Calabrese JR, Dunner DL, et al. Multi-site data reanalysis: validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV. Am J Psychiatry 1994;151:506-515
34. Cho JT, Bone S, Dunner DL, et al. The effect of lithium on thyroid function in patients with primary affective disorder. Am J Psychiatry 1979;136: 115-116
35. Cowdry RW, Wehr TA, Zis AP, et al. Thyroid abnormalities associated with rapid cycling bipolar illness. Arch Gen Psychiatry 1983;40:414-420
36. Joffe RT, Kutcher S, MacDonald C. Thyroid function and bipolar affective disorder. Psychiatry Res 1988;25:117-121
37. Bauer MS, Whybrow PC, Winokur A. Rapid cycling bipolar affective disorder, I: association with grade I hypothyroidism. Arch Gen Psychiatry 1990;47:427-432
38. Nurnberger JI Jr, Guroff JJ, Hamovit V, et al. A family study of rapid-cycling bipolar illness. J Affect Disord 1988;115:87-91
39. Dunner DL, Patrick V, Fieve RR. Rapid cycling manic depressive patients. Compr Psychiatry 1977;18:561-566
40. Calabrese JR, Woyshville MJ. A medication algorithm for treatment of bipolar rapid cycling? J Clin Psychiatry 1995;56(suppl 3):11-18
41. Stancer H, Persad E. Treatment of intractable rapid cycling manic-depressive disorder with levothyroxine. Arch Gen Psychiatry 1982;39:311-312
42. Bauer MS, Whybrow PC. Rapid cycling bipolar affective disorder, II: treatment of rapid cycling with high dose levothyroxine: a preliminary study. Arch Gen Psychiatry 1990;47:435-440
43. Vanell JM, Loo H, Galinoswki A, et al. Maintenance ECT in intractable manic depressive disorder. Convuls Ther 1994;10:195-205
44. Calabrese JR, Fatemi SH, Woyshville MJ. Diagnosis and treatment of rapid-cycling bipolar disorder. In: Dunner DL, ed. Current Psychiatric Therapy, II. Philadelphia, Pa: WB Saunders Company; 1997:266-271
45. Howland RH, Thase ME. A comprehensive review of cyclothymic disorder. J Nerv Ment Dis 1993;181:485-493
46. Akiskal HS, Khani MK, Scott-Strauss A. Cyclothymic temperamental disorders. Psychiatr Clin North Am 1979;2:527-554
47. Peselow ED, Dunner DL, Fieve RR, et al. Prophylactic effect against depression in cyclothymic patients: a life-table analysis. Compr Psychiatry 1981;22:257-264
48. Krauthammer C, Klerman GL. Secondary mania: manic syndrome associated with antecedent physical illness on drugs. Arch Gen Psychiatry 1978; 38:1333-1339
49. Ananth J, Wohl M, Ranganath V, et al. Rapid cycling patients: conceptual and etiological factors. Neuropsychology 1993;27:193-198
50. Winokur G, Coryell W, Akiskal HS, et al. Alcoholism in manic-depressive (bipolar) illness: familial illness, course of illness, and the primary-secondary distinction. Am J Psychiatry 1995;152:365-372
51. Feinman J, Dunner DL. The effect of alcohol and substance abuse on the course of bipolar affective disorders. J Affect Disord 1996;37:43-49
52. Wolpert EA, Goldberg JF, Harrow M. Rapid cycling in unipolar and bipolar affective disorders. Am J Psychiatry 1990;147:725-728
53. Kukopulos A, Reginaldi D, Laddomada P, et al. Course of the manic-depressive cycle and changes caused by treatments. Pharmakopsychiatr Neuropsychopharmakol 1980;13:156-167
54. Haag H, Heidorn A, Haag M, et al. Sequence of affective polarity and lithium response: preliminary report on the Munich samples. Prog Neuropsychopharmcol Biol Psychiatry 1987;11:205-208
55. Grof E, Haag M, Grof P, et al. Lithium response and the sequence of episode polarities: preliminary report on a Hamilton sample. Prog Neuropsychopharmacol Biol Psychiatry 1987;11:199-203
56. Maj M, Pirozzi R, Starace F. Previous pattern of course of illness as a predictor of response to lithium prophylaxis in bipolar patients. J Affect Disord 1989;17:237-241
57. Dunner DL, Fleiss JL, Fieve RR. Lithium carbonate prophylaxis failure. Br J Psychiatry 1976;129:40-44
58. Prien RF, Kupfer DJ, Mansky PA, et al. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorder: report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry 1984; 41:1096-1104
59. Heninger GR, Charney DS, Stemberg DE. Lithium carbonate augmentation of antidepressant treatment: an effective prescription for treatment-refractory depression. Arch Gen Psychiatry 1983;40:1335-1342
60. Joffe RT, Singer W, Levitt AJ, et al. A placebo-controlled comparison of lithium and triodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry 1993;50:387-393
61. Mendelwicz J, Fieve RR, Stallone F, et al. Genetic history as a predictor of lithium response in manic depression illness. Lancet 1972;1:599-600
62. Maj M, Del Vecchio M, Starace F, et al. Prediction of affective psychosis response lithium prophylaxis. Acta Psychiatr Scand 1984;69:37-44
63. Smeraldi E, Petroccine A, Gasperini M, et al. Outcomes of lithium treatment as a tool for genetic studies in affective disorders. J Affect Disord 1984;6:139-151
64. Abou-Saleh MT, Coppen A. Who responds to prophylactic lithium? J Affect Disord 1986;10:115-125
65. Suppes T, Baldessarini RJ, Faedda GI, et al. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry 1991;48:1082-1088
66. Schou M. Is there a lithium withdrawal syndrome? an examination of the evidence. Br J Psychiatry 1993;163:514-518
67. Faedda GI, Tondo L, Baldessarini RJ, et al. Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar mood disorders. Arch Gen Psychiatry 1993;50:448-455
68. Baldessarini RJ, Tondo L, Floris G, et al. Reduced mortality after gradual discontinuation of lithium treatment for bipolar I and bipolar II disorders: a replication study. Am J Psychiatry 1979;154:551-553
69. Schou M. Forty years of lithium treatment. Arch Gen Psychiatry 1997;54: 9-13
70. Coppen A, Standish-Barry H, Baily J, et al. Long-term lithium and mortality [letter]. Lancet 1990;335:1347
71. Muller-Oerlinghausen B, Ahrens B, Volk J, et al. Reduced mortality of manic-depressive patients in long-term lithium treatment: an international collaborative study by IGSLI. Psychiatry Res 1991;36:329-331
72. Nilsson A. Mortality in recurrent mood disorders during periods on and off lithium: a complete population study in 362 patients. Pharmacopsychiatry 1995;28:8-13
73. Post RM, Leverich GS, Altshuler L, et al. Lithium-discontinuation-induced refractoriness: preliminary observations. Am J Psychiatry 1992; 149:1727-1729
74. Post RM, Leverich GS, Pazzaglia P, et al. Lithium tolerance and discontinuation as pathways to refractoriness. In: Birch NJ. Padgham C, Hughes MS, eds. Lithium in Medicine and Biology. Carnforth, United Kingdom: Marius Press; 1993;71-84
75. Koukopoulos A, Reginald D, Minnai G, et al. The long-term prophylaxis of affective disorders. In: Gessa GL, Fratta W, Pani L, et al, eds. Advances in Biochemical Pharmacology, vol 49. New York, NY: Raven Press; 1995: 127-147
76. Maj M, Pirozzi R, Magliano L. Nonresponse to reinstituted lithium prophylaxis in previously responsive bipolar patients: prevalence and predictors. Am J Psychiatry 1995;152:1810-1811
77. Berghofer A, Muller-Oerlinghausen B. No loss efficacy after discontinuation and reinstitution of long-term lithium treatment? In: Gallicchio VS, Birch NJ, eds. Lithium: Biochemical and Clinical Advances. Cheshire, Conn: Weidner Publishing Group; 1996:39-46
78. Tondo L, Baldessarini RJ, Floris G, et al. Effectiveness of restarting lithium treatment after its discontinuation in bipolar I and bipolar II disorders. Am J Psychiatry 1997;154:548-550